Alkylamides from echinacea modulate induced immune responses in macrophages

Immunological Investigations

Volumn 36, Issue 2, 2007, Pages 117-130

  Matthias, A ^a   Banbury, L ^b   Stevenson, L M ^b   Bone, K M ^a,c   Leach, D N ^b   Lehmann, R P ^a  

^a MediHerb Research Laboratories   (Australia)

^b SOUTHERN CROSS UNIVERSITY   (Australia)

^c UNIVERSITY OF NEW ENGLAND   (Australia)

Author keywords

Alkylamide; Echinacea; Immune modulation; Macrophage

Indexed keywords

ECHINACEA ANGUSTIFLORA EXTRACT; ECHINACEA PURPUREA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BIOAVAILABILITY; ENZYME INHIBITION; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL LINE; ECHINACEA; IMMUNOLOGIC FACTORS; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; PLANT EXTRACTS; POLYUNSATURATED ALKAMIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33847739048     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130600745786     Document Type: Article

References (23)

1. Agnew, L. L., Guffogg, S. P., Matthias, A., Lehmann, R. P., Bone, K. M., Watson, K. (2005). Echinacea intake induces an immune response through altered expression of leukocyte hsp70, increased white cell counts and improved erythrocyte antioxidant defences. J. Clin. Pharm. Therap. 30:363-369.
2. Aktan, F., Henness, S., Roufogalis, B. D., Ammit, A. J. (2003). Gypenosides derived from Gynostemma pentaphyllum suppress NO synthesis in murine macrophages by inhibiting iNOS enzymatic activity and attenuating NF- κB-mediated iNOS protein expression. Nitric Oxide 8:235-242.
3. Bauer R., Jurcic, K., Puhlmann, J., Wagner, H. (1988). Immunologische In-vivo und In-vitro-Untersuchungen mit Echinacea-Extrakten. Arzneimittelforschung 38:276-281.
4. Bender, J. G., McPhail, L. C., van Epps, D. E. (1983). Exposure of human neutrophils to chemotactic factors potentiates activation of the respiratory burst enzyme. J. Immunol. 130:2316-2323.
5. Binns, S. E., Livesey, J. F., Arnason, J. T., Baum, B. R. (2002). Phytochemical variation in Echinacea from roots and flowerheads of cultivated populations. J. Agri. Food Chem. 50:3673-3687.
6. Bodinet, C., Willigmann, I., Beuscher, N. (1993). Host-resistance increasing activity of root extracts from Echinacea species. Planta Med. 59:A672-673.
7. Currier, N. L., Miller, S. C. (2000). Natural killer cells from aging mice treated with extracts from Echinacea purpurea are quantitatively and functionally rejuvenated. Exper. Gerontol. 35:627-639.
8. Felter, H. W., Lloyd, J. U. (1905). Echinacea. In: King's American Dispensatory. 18th Edition, 3rd revision. First published 1905, reprinted Eclectic Medical Publications, Portland; 1:671-677.
9. Forman, H. J., Torres, M. (2001). Redox signalling in macrophages. Mol. Aspects of Med. 22:189-216.
10. Gertsch, J., Schoop, R., Kuenzle, U., Suter, A. (2004). Echinacea alkylamides modulate TNF-α gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways. FEBS Lett. 577:563-569.
11. Goel, V., Chang, C., Slama, J., Barton, R., Bauer, R., Gahler, R., Basu, T. K. (2002). Echinacea stimulates macrophage function in the lung and spleen of normal rats. J. Nutr. Biochem. 13:487-492.
12. Hobbs, A. J., Higgs, A., Moncada, S. (1999). Inhibition of nitric oxide synthase as a potential therapeutic agent. Annu. Rev. Pharmacol. Toxicol. 39:191-220.
13. Kitchens, R. L., Munford, R. S. (1995). Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J. Biol. Chem. 270:9904-9910.
14. Komatsu, H., Tsukimori, K., Hata, K., Satoh, S., Nakano, H. (2001). The characterization of superoxide production of human neonatal neutrophil. Early Human Devel. 65:11-19.
15. Kuo, C. T., Chiang, L. L., Lee, C. N., Yu, M. C., Bai, K. J., Lee, H. M., Lee, W. S., Sheu, J. R., Lin, C. H. (2003). Induction of nitric oxide synthase in RAW 264.7 macrophages by lipoteichoic acid from Staphylococcus aureus: involvement of protein kinase-C and nuclear factor-kB-dependent mechanisms. J. Biomed. Sci. 10:136-145.
16. Lentner, C. (2003). Geigy Scientific Tables, volume 3. Ciba-Geigy, Basel, Switzerland p. 65.
17. Matthias, A., Addison, R. S., Penman, K. G., Dickinson, R. G., Bone, K. M., Lehmann, R. P. (2005). Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion. Life Sci. 77:2018-2029.
18. Matthias, A., Blanchfield, J. T., Penman, K. G., Toth, I., Lang, C.-S., De Voss, J. J., Lehmann, R. P. (2004). Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer model. J. Clin. Pharm. Therap. 29:7-13.
19. Randolph, R. K., Gellenbeck, K., Stonebrook, K., Brovelli, E., Qian, Y., Bankaitis-Davis, D., Cheronis, J. (2003). Regulation of human immune gene expression as influenced by a commercial blended Echinacea product: preliminary studies. Exp. Biol. Med. 228:1051-1056.
20. Rinninger, J. A., Kickner, S., Chigurupati, P., McLean, A., Franck, Z. (2000). Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells. J. Leuk. Biol. 68:503-510.
21. Sun, L. Z. Y., Currier, N. L., Miller, S. C. (1999). The American coneflower: a prophylactic role involving nonspecific immunity. J. Altern. Compl. Med. 5:437-446.
22. Wang, Y., Marsden, P. A. (1995). Nitric oxide synthases: gene structure and regulation. Adv. Pharmacol. 34:71-90.
23. Woelkart, K., Koidl, C., Grisold, A., Gangemi, J. D., Turner, R. B., Marth, E., Bauer, R. (2005). Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans. J. Clin. Pharmacol. 45:683-689.